Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 7, 2016, Pages 1360-1372

  Ozsarlak Sozer, G ^a   Sevin, G ^a   Ozgur, H H ^b   Yetik Anacak, G ^a   Kerry, Z ^a  

^a EGE UNIVERSITY   (Turkey)

^b Güne Pathology Laboratory   (Turkey)

Author keywords

Atherosclerosis; Buthionine sulfoximine; Inflammation; Rabbit; Taurine

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; GLUTATHIONE; INTERLEUKIN 1BETA; N(G) NITROARGININE; NITRIC OXIDE; PHENYLEPHRINE; SEROTONIN; TAURINE; TUMOR NECROSIS FACTOR; BUTHIONINE SULFOXIMINE; MALONALDEHYDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA CONSTRICTION; AORTA RELAXATION; AORTIC RING (SLICE); ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RABBIT MODEL; UPREGULATION; VASCULITIS; VASODILATATION; ANIMAL; AORTA; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; RABBITS AND HARES;

ACETYLCHOLINE; ANIMALS; AORTA; BUTHIONINE SULFOXIMINE; CAROTID ARTERIES; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MALONDIALDEHYDE; NITRIC OXIDE; NITROARGININE; OXIDATIVE STRESS; RABBITS; TAURINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85017163822     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. JAIN A, MARTENSSON J, MEHTA T, KRAUSS AN, AULD PA, MEISTER A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant, and skeletal muscle. Proc Natl Acad Sci U S A 1992;89:5093-5097.
2. EXNER R, WESSNER B, MANHART N, ROTH E. Therapeut ic potent ial of glutathione. Wien Klin Wochenschr 2000;112:610-616.
3. MARCINKIEWICZ J, KONTNY E. Taurine and inflammatory diseases. Amino Acids 2014;46:7-20.
4. YAMORI Y, LIU L, IKEDA K, MIURA A, MIZUSHIMA S, MIKI T, NARA Y; WHO-CARDIOVASCULAR DISEASE AND ALIMENTARY COMPRARISON (CARDIAC) STUDY GROUP. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 2001;24:453-457.
5. YAMORI Y, LIU L, MORI M, SAGARA M, MURAKAMI S, NARA Y, MIZUSHIMA S. Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 2009;643:13-25.
6. SUN Q, WANG B, LI Y, SUN F, LI P, XIA W, ZHOU X, LI Q, WANG X, CHEN J, ZENG X, ZHAO Z, HE H, LIU D, ZHU Z. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, double-blind, placebocontrolled study. Hypertension 2016;67:541-549.
7. CERESER C, GUICHARD J, DRAI J, BANNIER E, GARCIA I, BOGET S, PARVAZ P, REVOL A. Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. J Chromatogr B Biomed Sci Appl 2001;752:123-132.
8. LYKKESFELDT J. Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 2001;47:1725-1727.
9. MARTENSSON J, JAIN A, STOLE E, FRAYER W, AULD PA, MEISTER A. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A 1991;88:9360-9364.
10. LIMON-PACHECO JH, HERNANDEZ NA, FANJUL-MOLES ML, GONSEBATT ME. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic Biol Med 2007;43:1335-1347.
11. WATANABE T, SAGISAKA H, ARAKAWA S, SHIBAYA Y, WATANABE M, IGARASHI I, TANAKA K, TOTSUKA S, TAKASAKI W, MANABE S. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S, R) - sulfoximine. J Toxicol Sci 2003;28:455-469.
12. GANAFA AA, SOCCI RR, EATMAN D, SILVESTROVA N, ABUKHALAF IK, BAYORH MA. Acute inhibition of glutathione biosynthesis alters endothelial function and blood pressure in rats. Eur J Pharmacol 2002;454:217-223.
13. IWATA C, WANG X, UCHIDA K, NAKANISHI N, HATTORI Y. Buthionine sulfoximine causes endothelium dependent hyper-relaxation and hypoadiponectinemia. Life Sci 2007;80:873-878.
14. VAZIRI ND, WANG XQ, OVEISI F, RAD B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
15. HARAMAKI N, IKEDA H, TAKAJO Y, KATOH A, KANAYA S, SHINTANI S, HARAMAKI R, MUROHARA T, IMAIZUMI T. Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione. Arterioscler Thromb Vasc Biol 2001;21:1852-1856.
16. CATTAN V, MERCIER N, GARDNER JP, REGNAULT V, LABAT C, MAKI-JOUPPILA J, NZIETCHUENG R, BENETOS A, KIMURA M, AVIV A, LACOLLEY P. Chronic oxidative stress induces a tissue-specific reduction in telomere length in CAST/Ei mice. Free Radic Biol Med 2008;44:1592-1598.
17. BANDAY AA, MUHAMMAD AB, FAZILI FR, LOKHANDWALA M. Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 2007;49:664-671.
18. GOKCE G, OZSARLAK-SOZER G, OKTAY G, KIRKALI G, JARUGA P, DIZDAROGLU M, KERRY Z. Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo. Biochemistry 2009;48:4980-4987.
19. OZSARLAK-SOZER G, KERRY Z, GOKCE G, ORAN I, TOPCU Z. Oxidative stress in relation to telomere length maintenance in vascular smooth muscle cells following balloon angioplasty. J Physiol Biochem 2011;67:35-42.
20. GOKCE G, OZSARLAK-SOZER G, ORAN I, OKTAY G, OZKAL S, KERRY Z. Taurine suppresses oxidative stress-potentiated expression of lectin-like oxidized low-densi ty l ipoprotein receptor and restenosis in balloon-injured rabbit iliac artery. Clin Exp Pharmacol Physiol 2011;38:811-818.
21. SEVIN G, OZSARLAK-SOZER G, KELES D, GOKCE G, REEL B, OZGUR HH, OKTAY G, KERRY Z. Taurine inhibits increased MMP-2 expression in a model of oxidative stress induced by glutathione depletion in rabbit heart. Eur J Pharmacol 2013;706:98-106.
22. KURIYAMA H, KITAMURA K, NABATA H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev 1995;47:387-573.
23. FORD RJ, GRAHAM DA, DENNISS SG, QUADRILATERO J, RUSH JW. Glutathione depletion in vivo enhances contraction and attenuates endothelium-dependent relaxation of isolated rat aorta. Free Radic Biol Med 2006;40:670-678.
24. DENNISS SG, LEVY AS, RUSH JW. Effects of glutathionedepleting drug buthionine sulfoximine and aging on activity of endothelium-derived relaxing and contracting factors in carotid artery of Sprague-Dawley rats. J Cardiovasc Pharmacol 2011;58:272-283.
25. OVEY IS, NAZIROGLU M. Homocysteine and cytosolic GSH depletion induce apoptosis and oxidative toxicity through cytosolic calcium overload in the hippocampus of aged mice: involvement of TRPM2 and TRPV1 channels. Neuroscience 2015;284:225-233.
26. MORELLI MB, AMANTINI C, NABISSI M, LIBERATI S, CARDINALI C, FARFARIELLO V, TOMASSONI D, QUAGLIA W, PIERGENTILI A, BONIFAZI A, DEL BELLO F, SANTONI M, MAMMANA G, SERVI L, FILOSA A, GISMONDI A, SANTONI G. Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation. BMC Cancer 2014;14:921.
27. AIT-OUFELLA H, TALEB S, MALLAT Z, TEDGUI A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:969-979.
28. AKIN D, GURDAL H. Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery. Br J Pharmacol 2002;136:177-182.
29. ELLWOOD AJ, CURTIS MJ. Involvement of 5-HT (1B/1D) and 5-HT2A receptors in 5-HTinduced contraction of endothelium-denuded rabbit epicardial coronary arteries. Br J Pharmacol 1997;122:875-884.
30. ABEBE W, MOZAFFARI MS. Role of taurine in the vasculature: an overview of experimental and human studies. Am J Cardiovasc Dis 2011;1:293-311.
31. SCHAFFER SW, ITO T, AZUMA J. Clinical significance of taurine. Amino Acids 2014;46:1-5.
32. MURAKAMI S. Taurine and atherosclerosis. Amino Acids 2014;46:73-80.
33. ABEBE W, MOZAFFARI MS. Effects of chronic taurine treatment on reactivity of the rat aorta. Amino Acids 2000;19:615-623.
34. ABEBE W, MOZAFFARI MS. Taurine depletion alters vascular reactivity in rats. Can J Physiol Pharmacol 2003;81:903-909.
35. NISHIDA S, SATOH H. Vascular modulation of rat aorta by taurine. Adv Exp Med Biol 2009;643:37-46.
36. LIU Y, NIU L, ZHANG W, CUI L, ZHANG X, LIANG Y, ZHANG M. Effects of taurine on contractions of the porcine coronary artery. Pharmacol Rep 2009;61:681-689.
37. KAMATA K, SUGIURA M, KOJIMA S, KASUYA Y. Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. Eur J Pharmacol 1996;303:47-53.
38. SEVIN G, OZZAYIM O, DERELI MV, ANACAK GY. PP104 - The role of hydrogen sulfide on the regulation of vascular tonus in mice aorta and relation with taurine. Nitric Oxide 2015;47 Suppl:S56.
39. PATACCHINI R, SANTICIOLI P, GIULIANI S, MAGGI CA. Pharmacological investigation of hydrogen sulfide (H2S) contractile activity in rat detrusor muscle. Eur J Pharmacol 2005;509:171-177.
40. KIM JY, PARK HJ, UM SH, SOHN EH, KIM BO, MOON EY, RHEE DK, PYO S. Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-alphastimulated mouse vascular smooth muscle cells: involvement of the MAPK, NF-kappaB and AP-1 signaling pathways. Vasc Pharmacol 2012;56:131-141.
41. SPECIALE A, ANWAR S, RICCIARDI E, CHIRAFISI J, SAIJA A, CIMINO F. Cellular adaptive response to glutathione depletion modulates endothelial dysfunction triggered by TNF-alpha. Toxicol Lett 2011;207:291-297.